Gonadorelin
GnRH · LHRH · Luteinizing Hormone-Releasing Hormone
Gonadorelin is synthetic native GnRH (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2). Pulsatile pumps (historical Lutrepulse) and diagnostic Factrel are the medical story. Community twice-weekly TRT “preservation” shots are not that pump. Continuous exposure downregulates the axis. Score it as hormonal, not as a recovery peptide just because the catalog filed it there.
Use-case scores
0–10 against the evidence we have, not a gym ranking. Hidden domains do not apply here.
- Sexual / hormonal7/10
Native GnRH is a real diagnostic and pulsatile-fertility drug class. Ceiling 9 for approved use; haircut because twice-weekly TRT folklore is not Lutrepulse and Factrel is not a research-chem PCT kit.
Compound card
- Sequence
- pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2
- Class
- Native-sequence GnRH (diagnostic / pulsatile pump drug class)
- Formula
- C55H75N17O13
- Status
- FDA-approved
How it works
Gonadorelin is synthetic native GnRH, the hypothalamic decapeptide Schally sequenced in 1971 (Science, PMID 4938639). Pulsatile exposure releases LH and FSH. Continuous exposure downregulates the pituitary. That second fact is why depot agonists (leuprolide, triptorelin depot) chemically castrate, and why a research-chem daily drip is the wrong shape.
Factrel was a US diagnostic. Lutrepulse-style pumps dosed micrograms every ~90 minutes for hypogonadotropic hypogonadism. Community twice-weekly 100 mcg next to a testosterone shot is not that pump. It is a hope that a sparse pulse preserves testicular volume. hCG is the more common TRT adjunct with a different mechanism (LH-receptor agonist at the testis, skipping the pituitary).
This catalog files gonadorelin under recovery. Score it sexual/hormonal. It does not repair tendons.
Source: PMID: 1903034
Pulse vs suppression
Native GnRH only stimulates when it is pulsatile. A second peptide on this site, triptorelin, is the long agonist that can do the opposite. Do not stack them as a “restart.”
Goal context
TRT and fertility
Exogenous testosterone suppresses LH/FSH. Preserving spermatogenesis is a clinic problem (hCG, FSH, pulsatile GnRH pumps). A twice-weekly research shot is not a fertility program.
Not triptorelin
Triptorelin is a D-Trp6 agonist with depot cancer labels. Native gonadorelin is shorter-acting. Mixing them is how people accidentally shut the axis down.
Background & History
Gonadorelin is synthetic native GnRH (Schally 1971). Pulsatile exposure releases LH/FSH; continuous exposure downregulates. Factrel was a diagnostic. Lutrepulse-style pumps fire micrograms every ~90 min. Community twice-weekly TRT shots are not that pump. Filed under recovery in this catalog; physiology is HPG.
Research Use Cases
- ✓Native GnRH identity (vs triptorelin depot agonists)
- ✓Historical diagnostic bolus / pulsatile pump medicine
- ✓Not a proven twice-weekly fertility-preservation protocol on TRT
Dosing
| Phase | Dose | Frequency | Notes |
|---|---|---|---|
| Diagnostic (historical Factrel class) | 100 mcg | Single IV or SC bolus | Stimulation test, not a cycle. |
| Community TRT adjunct (unlabeled) | 100 mcg | 2× weekly SC | Folklore next to testosterone. Not Lutrepulse. Not proven equivalent to hCG. |
| Pump medicine (clinician) | 1–20 mcg | Every ~90 min | This is the actual pulsatile therapy shape. Not a reconstitution-calculator default. |
Administration
Timeline
Who it is for
Need native GnRH identity
HighThis is the decapeptide. Diagnostic and pump literature live here.
Need a depot agonist
LowThat is triptorelin/leuprolide. Different page, opposite chronic effect.
Reconstitution
| Vial | Water | Concentration | Example dose |
|---|---|---|---|
| 2 mg | 2.0 mL BAC | 1 mg/mL | 100 mcg = 0.10 mL = 10 units on a U-100 syringe |
Change vial size or water volume? Open the reconstitution calculator.
Safety & Considerations
Native GnRH class. Diagnostic and pump use have medical safety files. Research-chem vials do not. Continuous exposure suppresses the axis. This is not a tendon peptide. Fertility care belongs with an endocrinologist.
Regulatory & Legal Status
FDA-approved as Factrel®; widely used off-label as Gonadorelin Acetate in TRT protocols
Competitive athletes subject to anti-doping controls should not use Gonadorelin.
Compounded Drug (Rx)
US Compounding: Available via licensed pharmacy Rx
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Limits of current evidence
- Factrel diagnostic approval is not a TRT-adjunct label for gray-market vials.
- Pulsatile pump data (every ~90 min) does not transfer to twice-weekly community shots.
- Continuous or high-frequency exposure can suppress LH/FSH. That is the agonist-depot trick, not a feature of “more is better.”
- No recovery/tendon indication. Miscategorized in this catalog’s filter, not in physiology.
Verdict
Gonadorelin is native GnRH. Use a pump or a diagnostic protocol if that is the medical job. Do not treat 100 mcg twice a week as proven fertility preservation, and do not file this as a recovery peptide.
Interactions & Contraindications
Continuous or high-frequency exposure can suppress LH/FSH. That is the depot-agonist trick. hCG acts at the testis, skipping the pituitary. Antiandrogens blunt downstream testosterone.
Synergies & Common Stacks
Do not stack them as a restart. Native pulses vs long-agonist suppression are opposite chronic jobs.
Frequently Asked Questions
Is gonadorelin the same as triptorelin?▼
Does twice-weekly gonadorelin preserve fertility on TRT?▼
Why is the half-life so short?▼
How do I reconstitute a 2 mg vial?▼
Is Factrel still a thing?▼
Can I use it for PCT instead of a SERM?▼
Why is this in the recovery category?▼
WADA?▼
References
- Schally AV, Arimura A, Kastin AJ, Matsuo H, et al. “Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones.” Science (1971). PMID: 4938639
- Conn PM, Crowley WF Jr “Gonadotropin-releasing hormone and its analogues.” N Engl J Med (1991). PMID: 1984190
- Al-Inany HG, et al. “GnRH agonist and antagonist treatment protocols for assisted reproduction.” Cochrane Database Syst Rev (2016). PMID: 27126581
📚 Related Articles
Looking for a trusted source? See our recommended suppliers
Independently tested · COA-verified · Save 10% with our exclusive code